This vaccine is indicated for the combined prevention of measles, mumps and rubella in children from 9-12 months of age.
Vaccines, Anti-sera & Immunoglobulin
Dosage: In any case, do strictly conform to your doctor's prescription. The first injection is administered from the age of 9-12 months and the second injection is recommended between 4 and 6 years of age. Mode and route of administration: Subcutaneous or intramuscular route. this vaccine is in the form of a powder. After reconstitution, it is clear, yellow to purple red. Any reconstituted vaccine should be used immediately.
Congenital or acquired immunodepressions (including infections by the human immunodeficiency virus HIV). HIV-infected individuals who are not severely immunocompromised might be vaccinated after advice from a specialized team. True allergy to egg proteins (anaphylactic reaction after eating eggs). Recent injection of immunoglobulins
Generally pain and tenderness at the injection site may occur within 24 hours after vaccination,Severe fever reaction,Allergic rash,Allergic rash,Anaphylactoid purpura
Pregnancy , however vaccination during an unknown pregnancy does not justify advising termination of the pregnancy.
Keep out of the reach and sight of children. Store at +2°C to +8°C. Transportation should also be at +2°C to +8°C. Do not freeze. Discard vaccine if frozen. Protect from light.
Each vial contains lyophilized preparation of live attenuated Measles virus (Long-47 strain) grown in chicken embryo cell cultures and live attenuated Rubella virus (RA27/3 strain) grown in human diploid cell. After reconstitution each 0.5 ml contains live, attenuated measles virus USP≥ 1000 CCID50 and live, attenuated rubella virus USP ≥1000 CCID50.
.png&w=384&q=75)